| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Office of Research (HFT-100), National Center for Toxicological Research, Jefferson, Arkansas 72079 [H-C. C., F. F. K.], and Departments of Pharmacology and Toxicology [H-C. C., F. F. K.] and Surgery [N. P. L.], University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
Several N-hydroxy metabolites of carcinogenic arylamines and heterocyclic amines were examined as substrates for bioactivation by human liver sulfotransferases (STs). Among the N-hydroxy derivatives studied, N-hydroxy-2-acetylaminofluorene, N-hydroxy-2-aminofluorene, N-hydroxy-4,4'-methylene-bis(2-chloroaniline), N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and N-hydroxy-2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole were each metabolically activated by 3'-phosphoadenosine-5'-phosphosulfate-dependent human liver STs. No ST-mediated DNA binding of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline or N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline was detected under our assay conditions. In the 12 human hepatic cytosols studied, the extent of 3'-phosphoadenosine-5'-phosphosulfate-dependent DNA binding of the N-hydroxy derivatives were all significantly correlated with levels of thermostable phenol ST (TS-PST) activity but not with thermolabile phenol ST or dehydroepiandrosterone ST activities. The propensity of these N-hydroxy arylamines and N-hydroxy heterocyclic amines to serve as selective substrates for human TS-PST was further confirmed by inhibition with 2,6-dichloro-4-nitrophenol and by thermostability studies.
N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and N-hydroxy-4,4'-methylene-bis(2-chloroaniline) were also used as substrates to study ST-dependent metabolic activation in other human tissue preparations. 3'-phosphoadenosine-5'-phosphosulfate-dependent DNA binding activity was detected in human liver and colon cytosols but not in pancreas, larynx, or urinary bladder epithelial cytosols. Since the TS-PST appears to be expressed polymorphically in human populations, the finding that human TS-PST is capable of metabolically activating N-hydroxy metabolites of several carcinogenic arylamines and heterocyclic amines suggests that TS-PST may have an important role in determining interindividual susceptibility to these environmental and dietary carcinogens.
1 Present address: National Institute of Preventive Medicine, Department of Health, 161 Kun-Yang Street, Nankang, Taipei, Taiwan, Republic of China.
2 To whom requests for reprints should be addressed.
Received 7/14/94. Accepted 11/30/94.
This article has been cited by other articles:
![]() |
Y.-T. Chung, L.-L. Hsieh, I-H. Chen, C.-T. Liao, S.-H. Liou, C.-W. Chi, Y.-F. Ueng, and T.-Y. Liu Sulfotransferase 1A1 haplotypes associated with oral squamous cell carcinoma susceptibility in male Taiwanese Carcinogenesis, February 1, 2009; 30(2): 286 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Tang, J. J. Liu, A. Rundle, C. Neslund-Dudas, A. T. Savera, C. H. Bock, N. L. Nock, J. J. Yang, and B. A. Rybicki Grilled Meat Consumption and PhIP-DNA Adducts in Prostate Carcinogenesis Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 803 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wu, E. Giovannucci, C. Byrne, E. A. Platz, C. Fuchs, W. C. Willett, and R. Sinha Meat mutagens and risk of distal colon adenoma in a cohort of u.s. Men. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1120 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagar, S. Walther, and R. L. Blanchard Sulfotransferase (SULT) 1A1 Polymorphic Variants *1, *2, and *3 Are Associated with Altered Enzymatic Activity, Cellular Phenotype, and Protein Degradation Mol. Pharmacol., June 1, 2006; 69(6): 2084 - 2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. U. Gamage, S. Tsvetanov, R. G. Duggleby, M. E. McManus, and J. L. Martin The Structure of Human SULT1A1 Crystallized with Estradiol: AN INSIGHT INTO ACTIVE SITE PLASTICITY AND SUBSTRATE INHIBITION WITH MULTI-RING SUBSTRATES J. Biol. Chem., December 16, 2005; 280(50): 41482 - 41486. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nowell, B. Green, Y. M. Tang, R. Wiese, and F. F. Kadlubar Examination of Human Tissue Cytosols for Expression of Sulfotransferase Isoform 1A2 (SULT1A2) Using a SULT1A2-Specific Antibody Mol. Pharmacol., February 1, 2005; 67(2): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Barnett, S. Tsvetanov, N. Gamage, J. L. Martin, R. G. Duggleby, and M. E. McManus Active Site Mutations and Substrate Inhibition in Human Sulfotransferase 1A1 and 1A3 J. Biol. Chem., April 30, 2004; 279(18): 18799 - 18805. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nowell, D. L. Ratnasinghe, C. B. Ambrosone, S. Williams, T. Teague-Ross, L. Trimble, G. Runnels, A. Carrol, B. Green, A. Stone, et al. Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 270 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African Americans and Caucasians: SUSAN NOWELL, D. LUKE RATNASINGHE, SUZANNE WILLIAMS, TERRI TEAGUE-ROSS, LINDSAY TRIMBLE, BRIDGETT GREEN, ANGIE STONE, GRAHAM GREENE, CHRISTINE B. AMBROSONE, NICHOLAS P. LANG, AND FRED F. KADLUBAR, National Center for Toxicological Research, Jefferson, Arkansas 72079; Central Arkansas Veteran's Healthcare System, Little Rock, Arkansas 72205 and University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205 Toxicol Pathol, January 1, 2004; 32(1): 160 - 160. [PDF] |
||||
![]() |
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Arlt, H. Glatt, E. Muckel, U. Pabel, B. L. Sorg, H. H. Schmeiser, and D. H. Phillips Metabolic activation of the environmental contaminant 3-nitrobenzanthrone by human acetyltransferases and sulfotransferase Carcinogenesis, November 1, 2002; 23(11): 1937 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Salim, H. Wanibuchi, K. Morimura, T. Murai, S. Makino, T. Nomura, and S. Fukushima Induction of tumors in the colon and liver of the immunodeficient (SCID) mouse by 2-amino-3-methylimidazo[4,5-f ]quinoline (IQ)--modulation by long-chain fatty acids Carcinogenesis, September 1, 2002; 23(9): 1519 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-L. Steffensen, H. A. J. Schut, J. E. Paulsen, A. Andreassen, and J. Alexander Intestinal Tumorigenesis in Multiple Intestinal Neoplasia Mice Induced by the Food Mutagen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal Susceptibility, Regional Variation, and Correlation with DNA Adducts Cancer Res., December 1, 2001; 61(24): 8689 - 8696. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. H. Coughtrie and L. E. Johnston Interactions between Dietary Chemicals and Human Sulfotransferases{---}Molecular Mechanisms and Clinical Significance Drug Metab. Dispos., April 1, 2001; 29(4): 522 - 528. [Abstract] [Full Text] |
||||
![]() |
N. J. Gooderham, S. Murray, A. M. Lynch, M. Yadollahi-Farsani, K. Zhao, A. R. Boobis, and D. S. Davies Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans Drug Metab. Dispos., April 1, 2001; 29(4): 529 - 534. [Abstract] [Full Text] |
||||
![]() |
A. J. Fretland, U. S. Devanaboyina, Y. Feng, M. A. Leff, G. H. Xiao, S. J. Webb, and D. W. Hein Oral Administration of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Yields PhIP-DNA Adducts but Not Tumors in Male Syrian Hamsters Congenic at the N-acetyltransferase 2 (NAT2) Locus Toxicol. Sci., February 1, 2001; 59(2): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Frame, S. Ozawa, S. A. Nowell, H.-C. Chou, R. R. DeLongchamp, D. R. Doerge, N. P. Lang, and F. F. Kadlubar A Simple Colorimetric Assay for Phenotyping the Major Human Thermostable Phenol Sulfotransferase (SULT1A1) Using Platelet Cytosols Drug Metab. Dispos., September 1, 2000; 28(9): 1063 - 1068. [Abstract] [Full Text] |
||||
![]() |
R. S. King, C. H. Teitel, and F. F. Kadlubar In vitro bioactivation of N-hydroxy-2-amino-{alpha}-carboline Carcinogenesis, July 1, 2000; 21(7): 1347 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wyss and R. Kaddurah-Daouk Creatine and Creatinine Metabolism Physiol Rev, July 1, 2000; 80(3): 1107 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Purewal, M. Velasco, A. J. Fretland, D. W. Hein, and M. J. Wargovich 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Induces a Higher Number of Aberrant Crypt Foci in Fischer 344 (Rapid) Than in Wistar Kyoto (Slow) Acetylator Inbred Rats Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 529 - 532. [Abstract] [Full Text] |
||||
![]() |
G. Paladino, B. Weibel, and C. Sengstag Heterocyclic aromatic amines efficiently induce mitotic recombination in metabolically competent Saccharomyces cerevisiae strains Carcinogenesis, November 1, 1999; 20(11): 2143 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Stillwell, R. J. Turesky, R. Sinha, and S. R. Tannenbaum N-Oxidative Metabolism of 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in Humans Excretion of the N2-Glucuronide Conjugate of 2-Hydroxyamino-MeIQx in Urine Cancer Res., October 1, 1999; 59(20): 5154 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shibutani, A. Fernandes, N. Suzuki, L. Zhou, F. Johnson, and A. P. Grollman Mutagenesis of the N-(Deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine DNA Adduct in Mammalian Cells. SEQUENCE CONTEXT EFFECTS J. Biol. Chem., September 24, 1999; 274(39): 27433 - 27438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Leff, P. N. Epstein, M. A. Doll, A. J. Fretland, U.-S. Devanaboyina, T. D. Rustan, and D. W. Hein Prostate-Specific Human N-Acetyltransferase 2 (NAT2) Expression in the Mouse J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 182 - 187. [Abstract] [Full Text] |
||||
![]() |
K. H. Dingley, K. D. Curtis, S. Nowell, J. S. Felton, N. P. Lang, and K. W. Turteltaub DNA and Protein Adduct Formation in the Colon and Blood of Humans after Exposure to a Dietary-relevant Dose of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 507 - 512. [Abstract] [Full Text] |
||||
![]() |
S. A. Nowell, J. S. Massengill, S. Williams, A. Radominska-Pandya, T. R. Tephly, Z. Cheng, C. P. Strassburg, R. H. Tukey, S. L. MacLeod, N. P. Lang, et al. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved Carcinogenesis, June 1, 1999; 20(6): 1107 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Malfatti, K. S. Kulp, M. G. Knize, C. Davis, J. P. Massengill, S. Williams, S. Nowell, S. MacLeod, K. H. Dingley, K. W. Turteltaub, et al. The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans Carcinogenesis, April 1, 1999; 20(4): 705 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A.J. Schut and E. G. Snyderwine DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis Carcinogenesis, March 1, 1999; 20(3): 353 - 368. [Abstract] [Full Text] [PDF] |
||||
![]() |
R M Harris, R J Hawker, M J S Langman, S Singh, and R H Waring Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis Gut, February 1, 1998; 42(2): 272 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Coughtrie Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism? Human and Experimental Toxicology, July 1, 1996; 15(7): 547 - 555. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |